Moreno V, Garrido P, Papadopoulos KP, De Miguel Luken MJ, et al. Tolerability and antitumor activity of cemiplimab, a human monoclonal anti-PD-1, as monotherapy in patients with pretreated non-small cell lung cancer (NSCLC): Data from the Phase 1 NSCLC expansion cohort. Lung Cancer 2021;155:151-155.
PMID: 33831732